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Aim. The aim of this systematic review was to analyze and synthesize available evidence for the eﬀects of somatic acupoint
stimulation (SAS) on cancer-related sleep disturbance in adults with cancer. Methods. Nine databases and four clinical trial
registries were searched from their inception to July 2019 to identify potential articles and registered trials. Two authors independently extracted data and appraised the methodological quality of the included studies. The included studies could not be
subjected to meta-analysis due to the signiﬁcant variations in SAS intervention protocols and outcome measurement instruments.
This systematic review therefore reported the results of the included trials narratively. Results. Seven studies were identiﬁed, which
involved 906 cancer patients. SAS protocols varied across trials without an optimal evidence-based standard intervention protocol
to manage cancer-related sleep disturbance. Sanyinjiao (SP6) was the most commonly selected acupoint. Manual acupuncture was
typically 15–30 min in duration and was conducted once a day or once a week for a period of 1–5 weeks, whereas self-administered
acupressure was typically 1–3 min in duration per point and was conducted once a day, such as during night time before going to
bed, for a period of 1–5 months. The results indicated that SAS could potentially relieve cancer-related sleep disturbance and
improve quality of life. Mild adverse eﬀects were reported in three of the included studies, but none of them performed a causality
analysis to clarify the association between the reported adverse events and the intervention. Conclusions. This systematic review
showed that SAS is a useful approach to relieving cancer-related sleep disturbance. However, research evidence on SAS for
managing cancer-related sleep disturbance has not been fully conclusive due to the limited number of existing clinical studies with
relatively small sample size and suboptimal methodological quality. Clinical trials with large sample size and robust methodology
are warranted in future research.

1. Introduction
Sleep disturbance is one of the most frequently reported
symptoms experienced by individuals aﬀected by cancer,
with a prevalence ranging from 14% to 93% [1–3]. Cancer-

related sleep disturbance is manifested as early morning
awakening, trouble falling asleep, and diﬃculty staying
asleep [4]. Cancer-related symptoms, such as anxiety, depression, fatigue, and pain, tend to be exacerbated by sleep
disturbance [5]. Sleep disturbance can cause signiﬁcant
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psychological distress in patients with cancer [6]. Sleep
disturbance also appreciably impairs the functional status
and quality of life (QoL) of patients with cancer [7]. Cancerrelated sleep disturbance has become an important health
issue, which can impair patient outcomes; however, this
problem has not yet been adequately addressed in health
care settings [8].
Somatic acupoint stimulation (SAS) is a broad term
that describes body acupoint stimulation methods, with
manual acupuncture and acupressure, to balance the excess or deﬁciency of Qi on the basis of traditional Chinese
medicine (TCM) theory [9]. Manual acupuncture entails
needle insertion into the body at speciﬁc acupoints,
whereas manual acupressure refers to the stimulation of
acupoints by applying pressure using the ﬁngers or thumbs
[10]. Multiple systematic reviews reported that SAS is a
safe and eﬀective therapy in managing sleep disturbance in
noncancerous populations [11–15]. Patients with cancer
would also prefer SAS to manage sleep disturbance given
that this approach elicits fewer side eﬀects than other
pharmacological treatment options [15, 16]. However,
eﬀects of SAS on cancer-related sleep disturbance have not
been fully conclusive in current clinical pracrtice and
research.
Clinical studies have examined the eﬀects of SAS on cancerrelated sleep disturbance with contradictory ﬁndings reported
[17–22]. Several small scale clinical trials (sample size ranged
from 10 to 94) reported that SAS can alleviate sleep disturbance
in patients with cancer [18–21], whereas another three-arm
clinical trial with 288 cancer patients showed no signiﬁcant
diﬀerences among the eﬀects of relaxing acupressure, stimulating acupressure, and control treatment on the sleep quality of
patients with cancer at week 10; only the relaxing acupressure
group reported signiﬁcantly better sleep quality than the control
group at week 6 [22].
One recent systematic review that evaluated the eﬀects of
acupuncture on insomnia in patients with cancer showed
that acupuncture might be superior to conventional medications and sham acupuncture for managing cancer-related
sleep disturbance [23]. However, this review excluded
acupressure as one of the most important and commonly
practised modalities of SAS, and included a small number of
clinical trials with limited sample size [23], all of which
contributed to inconclusive evidence on SAS for managing
cancer-related sleep disturbance. Currently, researchers
have not reached consensus on the optimal acupoint formula or intervention dosage to apply SAS to manage cancerrelated sleep disturbance [19, 22]. Whether the existing
evidence is scientiﬁcally rigorous enough to support the use
of SAS for cancer-related sleep disturbance management
remains unclear.
This systematic review was therefore designed to further
explore the role and safety of SAS, including both body
acupuncture and body acupressure, for the alleviation of
cancer-related sleep disturbance. Speciﬁcally, this review
explored (1) the best available evidence for the eﬀects of SAS
on cancer-related sleep disturbance; (2) the commonly used
SAS intervention protocols to manage cancer-related sleep
disturbance; (3) the commonly utilized research instruments
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to assess cancer-related sleep quality; and (4) the safety and
cost-eﬀectiveness of using SAS for managing sleep disturbance in patients with cancer.

2. Methods
2.1. Study Selection. The Preferred Reporting Items for
Systematic Reviews and Meta-Analyses (PRISMA) checklist
[24] was used in determining the content required and
systematic process for this systematic review. The protocol of
this systematic review has been registered at PROSPERO
(no. CRD42019131609).
Nine databases were searched from their inception to
July 2019 for the identiﬁcation of potential articles and
registered trials published in English and Chinese. The
databases were Allied and Complementary Medicine,
Cochrane Central Register of Controlled Trials, Cumulative
Index to Nursing and Allied Health Literature, Excerpta
Medica Database, PsycINFO, PubMed, Web of Sciences,
Chinese Medical Literature Database, and Wanfang Database. The following trial registeries for ongoing or completed
trials were also searched: World Health Organization International Clinical Trials Registry Platform (https://www.
who.int/ictrp/trial_reg/en/), ClinicalTrials.gov (https://
clinicaltrials.gov/), National Research Register via the Department of Health, UK (http://www.dh.gov.uk), and the
Australian New Zealand Clinical Trials Registry (http://
www.anzctr.org.au/).
The search strategy examples are presented in Table 1
and the following MESH terms and keywords were used in
developing
electronic
search
strategies:
English:
“acupunctur∗”, “acupressur∗”, “acupoint∗”, “massag∗”
“sleep”, “insomnia”, “neoplasms”, “tumour”, “cancer”,
“malignan∗” “carcinoma∗”, and “oncolog∗”. Chinese: “针∗”,
“穴位∗”, “睡眠障碍”, “失眠”, “睡眠”, “肿瘤”, and “癌症”.
This systematic review developed an individualized search
strategy for each database and screened all the reference lists
of previous reviews and included studies for additional
relevant articles.
Two authors (X.L. Liu and H.L. Cheng) independently
assessed the titles and abstracts of all records identiﬁed
through the broad initial search. All duplicated records were
managed and subsequently excluded using EndNote X9. If
the detailed information from the titles and abstract was
unclear to the reviewers, the full text of the publications was
retrieved. The ﬁnal decision to include or exclude a trial was
based on an assessment of the full texts of all retrieved
publications and registered trials. Any disagreements during
these processes were settled by discussion with a third author
if necessary. An assessment Excel form detailing speciﬁc
reasons for the exclusion of publications was developed.
2.2. Inclusion Criteria
(1) Types of Study. Randomized controlled trials (RCTs). (2)
Participants. Adult patients with cancer reporting sleep
disturbance regardless of types or stages of cancer or previous cancer treatments. (3) Intervention(s). SAS: manual
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Table 1: Searching strategy examples.
Items
Searching strategy example
PubMed
(((acupuncture[MeSH terms]) OR acupuncture therapy[MeSH terms]) OR acupuncture points[MeSH terms]) OR acupressure
#1
[MeSH terms]
((((acupunctur∗ [Title/Abstract]) OR acupoin∗ [Title/Abstract]) OR acupressur∗ [Title/Abstract]) OR massag∗ [Title/Abstract]) OR
#2
plaster∗ [Title/Abstract]
#3
#1 OR #2
#4
(“neoplasms”[MeSH terms]) OR “cancer survivors”[MeSH terms]
((((((neoplasm∗ [Title/Abstract]) OR tumor∗ [Title/Abstract]) OR tumour∗ [Title/Abstract]) OR cancer∗ [Title/Abstract]) OR
#5
malignan∗ [Title/Abstract]) OR carcinoma∗ [Title/Abstract]) OR oncolog∗ [Title/Abstract]
#6
#4 OR #5
#7
((“sleep initiation and maintenance disorders”[MeSH terms])) OR “sleep wake disorders”[MeSH terms]
(((Sleep∗ [Title/Abstract]) OR insomnia“[Title/Abstract]) OR sleep disturbance∗ [Title/Abstract]) OR sleep disorder∗ [Title/
#8
Abstract]
#9
#7 OR #8
#10
#6 AND #9
#11
#3 AND #10
(((((((((“randomized controlled trial”[Publication Type]) OR “controlled clinical trial”[Publication Type]) OR “ramdomized”[Title/
#12
Abstract]) OR “ramdomised”[Title/Abstract]) OR “placebo”[Title/Abstract]) OR “sham”[Title/Abstract]) OR “randomly”[Title/
Abstract]) OR “trial”[Title/Abstract]) OR “groups”[Title/Abstract])
#13
#11 AND #12
#14
(animals[MeSH terms] NOT (humans[MeSH terms] AND animals[MeSH terms]))
#15
#13 NOT #14
Cochrane Central Register of Controlled Trials (CENTRAL)
#1
MeSH descriptor: [acupuncture] explode all trees
#2
MeSH descriptor: [acupuncture therapy] explode all trees
#3
MeSH descriptor: [acupuncture points] explode all trees
#4
MeSH descriptor: [acupressure] explode all trees
“acupunctur∗ ”:ti,ab, kw or acupoin∗ :ti,ab, kw or acupressur∗ :kw or massag∗ :ti,ab, kw or plaster∗ :ti,ab, kw (word variations have
#5
been searched)
#6
#1 or #2 or #3 or #4 or #5
#7
MeSH descriptor: [neoplasms] explode all trees
#8
MeSH descriptor: [cancer survivors] explode all trees
neoplasm∗ :ti,ab, kw or tumor∗ :ti,ab, kw or tumour∗ :ti,ab, kw or cancer∗ :ti,ab, kw or malignan∗ :ti,ab, kw or carcinoma∗ :ti,ab, kw or
#9
oncolog∗ :ti,ab, kw (word variations have been searched)
#10
#7 or #8 or #9
#11
#6 and #10
#12
MeSH descriptor: [sleep initiation and maintenance disorders] explode all trees
#13
MeSH descriptor: [sleep-wake disorders] explode all trees
Sleep∗ :ti,ab, kw or insomnia:ti,ab, kw or sleep disturbance∗ :ti,ab, kw or sleep disorder∗ :ti,ab, kw (word variations have been
#14
searched)
#15
#12 or #13 or #14
#16
#11 and #15
#17
Trials + Cochrane protocol
Embase Classic + Embase
#1
Acupuncture∗ .m_titl.
#2
Acupressur∗ .m_titl.
#3
acupoin∗ .m_titl.
#4
massag∗ .m_titl.
#5
#1 or #2 or #3 or #4
#6
Neoplasm∗ .mp. [mp � ti, ab, ot, nm, hw, kf, px, rx, ui, an, tx, sh, ct, sa, tn, dm, mf, dv, kw]
#7
“tumor∗ ”.m_titl.
#8
“tumour∗ ”.m_titl.
#9
cancer∗ .mp. [mp � ti, ab, ot, nm, hw, kf, px, rx, ui, an, tx, sh, ct, sa, tn, dm, mf, dv, kw]
#10
malignan∗ .mp. [mp � ti, ab, ot, nm, hw, kf, px, rx, ui, an, tx, sh, ct, sa, tn, dm, mf, dv, kw]
#11
carcinoma∗ .mp. [mp � ti, ab, ot, nm, hw, kf, px, rx, ui, an, tx, sh, ct, sa, tn, dm, mf, dv, kw]
#12
oncolog∗ .mp. [mp � ti, ab, ot, nm, hw, kf, px, rx, ui, an, tx, sh, ct, sa, tn, dm, mf, dv, kw]
#13
#6 or #7 or #8 or #9 or #10 or #11 or #12
#14
#5 and #13
#15
Sleep∗ .mp. [mp � ti, ab, ot, nm, hw, kf, px, rx, ui, an, tx, sh, ct, sa, tn, dm, mf, dv, kw]
#16
Insomnia∗ .mp. [mp � ti, ab, ot, nm, hw, kf, px, rx, ui, an, tx, sh, ct, sa, tn, dm, mf, dv, kw]
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Table 1: Continued.

Items
Searching strategy example
#17
sleep disturbance∗ .m_titl.
#18
sleep disorder∗ .m_titl.
#19
#15 or #16 or #17 or #18
#20
#14 and #19
Wanfang Database
题名或关键词: ((“针灸” + “穴位按压” + “穴位按摩” + “穴位”) ∗ (“失眠” + “睡眠障碍” + “睡眠”)

acupuncture or manual acupressure on the speciﬁc body
acupoints as interventions performed or taught by acupuncture practitioners, Chinese medicine practitioners,
nurses, or other health care professionals. All forms of
auricular acupoint stimulation, electronic acupoint stimulation, point injection, and transcutaneous electrical nerve
stimulation were excluded. (4) Control. Routine methods of
treatment for cancer-related sleep disturbance, sham
(placebo) SAS, or usual care. (5) Primary Outcomes. (a).
Cancer-related sleep disturbance and sleep quality measured by any validated tool and (b). self-reported hours of
sleep and sleep eﬃciency, determined by the ratio of the
total sleep time to the time spent in bed. (6) Secondary
Outcomes. (a). QoL; (b). satisfaction with SAS; (c). safety of
SAS, including any adverse events of SAS, such as dizziness
and local bleeding, and the number of participants dropping out due to adverse events; and (d). cost-eﬀectiveness
of SAS.

∗

(“癌症” + “肿瘤”+ “癌性”))

2.5. Strategies for Data Synthesis. Only descriptive analysis,
rather than meta-analysis, was conducted in this systematic
review because of the considerable clinical heterogeneity
identiﬁed in the SAS protocols, intervention dosages, time
points of data collections, and measures of study outcomes.
Meta-analysis has been deemed inappropriate for use in
systematic reviews with substantial clinical heterogeneity of
the included studies [26]. Clinical heterogeneity generally
refers to variability in the study participants, intervention
characteristics, and types or time points of outcome assessment [27]. In meta-analysis, credibility of the quantitative synthesis ﬁndings can be signiﬁcantly aﬀected by the
clinical heterogeneity of the analyzed studies, often skewing
the conclusions [27, 28]. Funnel plot and Egger’s bias test
were not performed to gauge potential publication bias in
this systematic review given that only seven trials were
included.

3. Results
2.3. Data Extraction. Two reviewers (X.L. Liu and H.L.
Cheng) worked independently to extract the data of the
included studies by using a predeﬁned data extraction
form. The research designs, study settings, patient demographics, SAS protocols (including the acupoint formula, intervention session, intervention duration and
frequency), comparisons, and outcomes were extracted. If
some data of the included studies were missing or unclear,
the reviewers contacted the original authors of the included studies to seek clariﬁcation.
2.4. Methodological Quality and Risk of Bias Assessment.
The risk of bias assessment tool, developed by the Cochrane
Back Review Group, was applied to assess the methodological quality and risk of bias of the included studies as
“high”, “low”, “unclear”, or “not applicable”. The tool
comprises a set of speciﬁc questions related to randomization and concealment of intervention allocation; participant, health care provider, and outcome assessor blinding;
cointervention avoidance; compliance; dropout rate; outcome assessment timing; selective reporting; and group
similarity [25]. Two reviewers (X.L. Liu and H.L. Cheng)
independently assessed the methodological quality and risk
of bias of the included RCTs. Further details were identiﬁed
by contacting the primary authors if the data were unavailable in the relevant reports. Any discrepancies between
the reviewers were reconciled through discussion or consultation with a third reviewer.

3.1. Selection of Studies. Figure 1 illustrates the PRISMA ﬂow
diagram of information through the review. This diagram
speciﬁes the number of records identiﬁed at each stage and
the reasons that records were removed. The title and abstract
of 495 potential records were reviewed. Following the inclusion and exclusion criteria, 40 abstracts appeared relevant
to the research questions were considered suitable for further evaluation of their full-texts. Then, 33 articles were
rejected at this stage because they did not meet the eligibility
criteria. Thus, seven studies, including ﬁve published studies
[19, 21, 22, 29, 30], and two registered ongoing or completed
trials [31, 32], were ﬁnally included in this systematic review.
3.2. Characteristics of the Included Trials. Table 2 provides a
summary of the seven studies included in this systematic
review. The included studies comprised 906 randomized
cancer patients. Only published articles (n = 5) reported
the number of patients who completed the intervention.
The average sample size of the included trials was 129
(range: 57–288). Six published studies or registered trials
were published in English [19, 21, 22, 30–32], and only
one study was published in Chinese [29]. The included
trials were conducted in Mainland China [21, 29], the
United States [22, 31], Denmark [19], Taiwan [30], and
Vietnam [32].
Three studies comprised two arms [21, 29, 31], and the
other studies comprised three arms. For control groups,
placebo (sham) group was used in four trials [19, 30–32].
Four studies targeted a single cancer type, such as lung

Identiﬁcation
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Records identiﬁed through
database searching
(n = 492: English 449, Chinese 43)

5

Additional records identiﬁed
through other sources
(n = 3)

Screening

Full-text articles assessed for
eligibility
(n = 40, including two registered
ongoing/completed studies)

Inclusion

Records screened for
title and/or abstract
(n = 441)

Eligibility

Records after 54 duplicates removed
(n = 441)

Removal based on exclusion
criteria (n = 401)

Full-text articles excluded
(n = 33)
(i) Inconsistent population (n = 4)
(ii) Inconsistent intervention (n = 15)
(iii) Inconsistent study type (n = 8)
(iv) Conference abstract (n = 6)

Studies included
(n = 7)

Figure 1: PRISMA ﬂow diagram for search results.

Table 2: Characteristics of RCTs examining somatic acupoint stimulation included in systematic review.
Intervention

First author,
year, setting

Study design

H.T. Hoang,
2019,
Vietnam [32]

Randomized
controlled
trial
(registered
ongoing/
completed
study)

S.M. Zick,
2016, USA
[22]

Randomized
controlled
trial
(published
study)

Sleeprelated
Sham/control Follow-up
Intervention group(s)
outcomes
group(s)
Placebo
comparator
group:
enhanced
Weekly
standard
ISI and
Self-acupressure group:
phone call
Randomized � 114,
Selfcare + sham
sleep
standard care and true selffollow-up
38 patients in each administered
selfparameter
acupressure intervention
(during the
group
acupressure
acupressure
in sleep
protocol
four-week
No
diary
intervention)
intervention
group:
enhanced
standard care
Randomized � 288
Completed � 228
Relaxing
acupressure group:
SelfRelaxing acupressure
74 (completed)
4-week
administered (intervention 1), stimulating Usual care
PSQI
Stimulating
follow-up
acupressure acupressure (intervention 2)
acupressure group:
70 (completed)
Usual care group:
84 (completed)
Participants (n)

SAS type
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Table 2: Continued.

First author,
year, setting

Intervention
Study design

Participants (n)

Randomized � 208
Randomized
Completed � 190
Y.L. Zhao,
controlled
Intervention group:
2015, China
study
93 (completed)
[29]
(published
Control drug
study, thesis)
group: 97
(completed)
Randomized � 57
Completed � 45
Experimental
Acupressure/oils
pilot study,
group: 15
W.R. Tan,
randomized
(completed)
2014, Taiwan
controlled
Acupressure only
[30]
study
group: 16
(published
(completed)
study
Control group: 14
(completed)
Randomized � 94
Completed � 94
Randomized Intervention group:
S. Bokmand,
controlled
31 (completed)
2013,
trial
Sham group: 29
Denmark
(published
(completed)
[19]
study)
No-treatment
group: 34
(completed)
Randomized � 80
Randomized
Completed � 80
controlled
Y. Feng, 2011,
Intervention group:
trial
China [21]
40 (completed)
(published
Control group: 40
study)
(completed)

S. David,
2010, USA
[31]

Randomized
controlled
trial
(registered
ongoing/
completed
study)

Randomized � 65;

SAS type

Intervention group(s)

Sham/control
group(s)

Follow-up

Acupuncture
(including
moxibustion
Control drug: 7-day followAcupuncture + moxibustion
as an
estazolam
up
additional
treatment)
Acupressure + oils group:
acupressure with 5%
essential oil; acupressure
Selfincludes kneading, pointing,
administered
pressing, and pushing.
acupressure
Acupressure only group:
includes kneading, pointing,
pressing, and pushing.

Sham
acupressure

Sleeprelated
outcomes

AIS and
PSQI

NR

PSQI

Sham group:
manual
acupuncture
in the selected
Manual
Manual acupuncture in the
sham points.
acupuncture selected acupuncture points
No-treatment
group:
received no
acupuncture.

NR

Disturbed
night sleep
(rated as
“yes” or
“no”)

Standard care
with
ﬂuoxetine
hydrochloride

NR

PSQI

Manual
Manual acupuncture on the
acupuncture
acupoints

Acupuncture

Acupuncture

A validated
sham
acupuncture
control

One month
following the
completion
of
intervention
Insomnia
and six
reduction
months after
the
conclusion
of
intervention

SAS: somatic acupoint stimulation; ISI: Insomnia Severity Index; PSQI: The Pittsburgh Sleep Quality Index; AIS: Athens insomnia scale; NR: not reported.

cancer [30] or breast cancer [19, 22, 31], whereas three
studies recruited patients with diﬀerent types of cancer
[21, 29, 32]. The average age of participants in the included trials was above 50 years old [19, 22, 29, 30]. Three
studies recruited only female patients with cancer
[19, 22, 31].
The commonly utilized research instruments to assess
cancer-related sleep was the Pittsburgh Sleep Quality
Index (PSQI), which was used in four trials [21, 22, 29, 30].
Two types of assessment instruments were used to assess
sleep disturbance and sleep quality in the included studies.
The ﬁrst type of instrument comprises qualitative

assessment tools, such as sleep diaries, which were used to
evaluate total sleep time (min), total time in bed (min), the
number of night awakenings after sleep onset, and sleep
eﬃciency [32]. The other type includes self-reported instruments, such as the Athens Insomnia Scale (AIS), the
Insomnia Severity Index (ISI), and the PSQI
[21, 22, 29, 30], which were used to quantify patients' sleep
quality.
3.3. Somatic Acupoint Stimulation Protocols. Two types of
SAS protocols were used in the included trials: (1) self-
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administered acupressure [22, 30, 32] and (2) manual needle
acupuncture [19, 21, 29, 31]. In one needle acupuncture
study, moxibustion was additionally used on two points:
Shenque (CV8) and Guangyuan (CV4) [29]. Sanyinjiao
(SP6) was used in ﬁve trials [19, 21, 22, 29, 30]. Yintang (EXHN3) and Baihui (DU/GV20) were used in four; Shenmen
(HT7), Zusanli (ST36), Taichong (LR3), and Neiguan (PC6)
were used in three; and Taixi (KI3) and Hegu (LI4) were used
in two. One registered trial did not report the selected
acupoints [31].
For the duration of SAS, manual acupuncture was
typically 15–30 min in duration and was conducted once a
day or once a week for a period of 1–5 weeks, whereas selfadministered acupressure was typically 1–3 min in duration
per point and was conducted once a day, such as during
night time before going to bed, from 1 to 5 months. For
manual acupuncture, the depth of needle insertion was
0.5–1.5 cun [29]. Participants' self-acupressure skills regarding acupoint location, acupressure intensity, and
stimulation techniques were taught by nurses who were
trained by the main researcher and a TCM professional (the
intervention protocol had been validated by six Chinese
medicine experts) [32], by acupressure educators who were
trained by the study investigator [acupuncturist] [22], or by
research assistants (RAs) who were trained by qualiﬁed
TCM practitioners [30]. One study used acupressure with oil
as an intervention [30].
The full details of the SAS protocols used in the included
studies are presented in Table 3.
3.4. Methodological Quality and Risk of Bias of the Included
Trials. Table 4 presents the methodological quality and risk
of bias summary of each included trial. Randomization was
mentioned in all seven RCTs, and six of which provided the
precise descriptions of the processes used to generate random sequences. Adequate allocation concealmentwas described in four RCTs (low risk of bias). Only ﬁve RCTs
reported a blind design for the participants and outcome
assessor (low risk of bias).
Common methodological issues identiﬁed across these
trials included limited information on the method of randomization, allocation concealment, cointerventions, and
study results. For example, limited information was used in
the assessment of the methodological quality of two registered studies because the full-text publications of these two
trials could not be found or have not been published yet
[31, 32]. Five items were not applicable to the two registered
studies [31, 32]. Only three published trials mentioned and
used intention-to-treat analysis [22, 29, 30]. Funnel plot
analysis was not feasible because of the scarcity of trials in
this systematic review.
3.5. Descriptive Analysis of Outcomes. The included studies
could not be subjected to meta-analysis due to the signiﬁcant
variations in SAS intervention protocols and outcome
measurement instruments. Thus, this systematic review
reported results from these included trials narratively.
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3.5.1. Pittsburgh Sleep Quality Index. Four of the included
trials reported PSQI scores [21, 22, 29, 30]. Two studies
reported a signiﬁcant between-group diﬀerence in PSQI
scores at the end of the study [21, 29]. In a three-arm RCT,
Tang et al. reported that PSQI scores in the acupuncture with
oil and acupuncture-only groups reduced compared with
that in the control group [30]. The adjusted PSQI score in the
acupressure with oil group changed signiﬁcantly compared
with that in the control group at day one of the third
chemotherapy cycle [30]. The change in the mean PSQI
score of the acupressure-only group was not as pronounced
as that of the control group at day one of the sixth chemotherapy cycle [30].
Another three-arm trial reported an improvement in the
PSQI scores in the two intervention groups—relaxing
acupressure and stimulating acupressure—when compared
with the control group but the diﬀerence did not reach
statistical signiﬁcance [22]. This study [22] reported that the
PSQI scores at week six in the relaxing acupressure group
were signiﬁcantly lower than PSQI scores in the control
treatment but were not signiﬁcantly diﬀerent from that in
the stimulating acupressure group. At week 10, no signiﬁcant diﬀerence between the three arms was observed [22].
3.5.2. Disturbed Night Sleep. Only one of the included
studies with a three-arm design used disturbed night sleep
(rated as “yes” or “no”) as a sleep quality index [19]. After 5
weeks of acupuncture intervention, the disturbed night sleep
of patients with breast cancer receiving acupuncture treatment showed a statistically signiﬁcant improvement compared with those receiving sham acupuncture or no
treatment [19]. The intervention eﬀects on disturbed night
sleep lasted for at least 12 weeks after the ﬁnal acupuncture
session [19].
3.5.3. Athens Insomnia Scale. Only one of the included
studies used the AIS to assess patients’ baseline condition but
did not report the post-intervention AIS data [29].
3.5.4. Insomnia Severity Index, Sleep Parameter in Sleep
Diary and Insomnia Reduction. Two ongoing or completed
registered trials used the ISI [31, 32], and one utilized the
sleep parameter [32].
3.5.5. Quality of Life (QoL). Two of the included trials reported data on QoL, which were measured by the LongTerm Quality of Life Instrument (LTQL) [22] and MOSSF36 [26]. In a three-arm RCT, Zick et al. reported that, at
week 6 and week 10, three of the four QoL subscales, including somatic, ﬁtness, and social support, improved more
in the relaxing acupressure group than the control group
[22]. No signiﬁcant improvement in QoL scores between the
stimulating acupressure group and the control group for any
subscale at either time point was observed [22]. Zhao's study
[29] did not ﬁnd any signiﬁcant diﬀerence in QoL scores
between the intervention and control groups.
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Table 3: Somatic acupoint stimulation protocols used in the included studies.

First author,
year, country

SAS type

Selected acupoints: no. and names

6: Baihui (DU/GV 20), Yintang
(EX-HN3), Fengchi (GB20),
Neiguan (PC6), Shenmen (HT7),
and Taichong (LR3)

H.T. Hoang,
2019, Vietnam
[32]

Self-acupressure

S.M. Zick,
2016, USA
[22]

Relaxing acupressure: 5: Yintang
(EX-HN3, centrally), Anmian
(bilaterally), heart 7 (Shenmen,
HT7, bilaterally), spleen 6
(Sanyinjiao, SP6, bilaterally), and
liver 3 (Taichong, LR3, bilaterally).
Self-administered Stimulating acupressure: 6: Baihui
acupressure
(DU/GV 20, centrally), conception
vessel 6 (Qihai, CV6, centrally),
large intestine 4 (Hegu, LI14,
bilaterally), stomach 36 (Zusanli,
ST36, bilaterally), spleen 6
(Sanyinjiao, SP6, bilaterally), and
kidney 3 (Taixi, KI3 bilaterally).

Y.L. Zhao,
2015, China
[29]

Acupuncture
(including
moxibustion)

Acupuncture: 6: Baihui (DU/
GV20), Shenting (GV24), Yintang
(EX-HN3), Shenmen (HT7),
Zusanli (ST36, bilaterally),
Sanyinjiao (SP6, bilaterally), and
Guangyuan (CV4).
Moxibustion: 2: Shenque (CV8)
and Guangyuan (CV4).

3: Hegu (LI4, bilaterally), Zusanli
(ST36, bilaterally), and Sanyinjiao
W.R. Tan,
(SP6, bilaterally).
Self-administered
2014, Taiwan
Acupressure with essential oils
acupressure
[30]
(group A): essential
oils were used for each acupoint
acupressure every time.
4: Neiguan (HC6, bilaterally), Taixi
S. Bokmand,
Manual
(KI3, bilaterally), Sanyinjiao (SP6,
2013,
acupuncture
bilaterally), and Taichong (LR3,
Denmark [19]
bilaterally)
9: Baihui (DU/GV 20), Fenglong
(ST 40), Neiguan (PC 6),
Y. Feng, 2011,
Manual
Sanyinjiao (SP 6), Sishencong (EXChina [21]
acupuncture
HN1), Shenmen (TF 4),
Yinlingquan (SP 9), Xuehai (SP
10), and Yintang (EX-HN3).
S. David, 2010,
Acupuncture
NR
USA [31]
NR: not reported.

SAS protocols
Responses
Total
Instructions of SAS
elicited
sessions
Daily acupressure at night with
stimulation for each acupoint
lasting 3 minutes, 24 minutes in
total.
Participants received a weekly
phone call follow-up
4 weeks (28
from the study investigator to
days, 28
NR
remind them to self-practice
sessions)
acupressure at home. Training:
participants
received a self-acupressure training
section at hospital from four trained
nurses.

NR

De qi

De qi

NR

NR

NR

Once per day. Participants were
required to stimulate the acupoint
in a circular motion with 3 minutes
6 weeks (42
for each acupoint.
sessions)
Training: patients were taught to
self-administer acupressure by a
trained acupressure educator.

Once per day for 7 days, 30 minutes
each time (acupuncture +
moxibustion).
Needle type (depths of insertion):
7 days (7
stainless steel (GV20 : 0.5–0.8 cun,
sessions)
GV24 : 0.5–0.8 cun, EX-HN3:
0.5–0.8 cun, HT7: 0.3–0.5 cun,
ST36 : 1.2–1.5 cun, SP6: 1.0–1.2 cun,
and CV4: 1.0–1.5 cun).
Daily application (6 min) on each
morning at the chosen acupoints,
and each acupoint should be
5 months
pressed in rotation for 1 minute. (around 150
Acupressure skills consist of
sessions)
pointing, pressing, kneading, and
pushing.
One treatment per week for 15–20
minutes.
5 weeks (5
Needle
sessions)
type (depths of insertion): NR (NR).
Daily treatment for 20–30 min.
Needling manipulation performed
by the acupuncturist at the interval 30 days (30
of 5–10 minutes.
sessions)
Needle
type (depths of insertion): NR (NR).
Approximately 20 minutes

10 sessions
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Table 4: Methodological quality assessment of included trials.
Trials

Item 1 Item 2 Item 3 Item 4 Item 5

Item
6

Item
7

Item 8

Item
9

Item
10

Item
11

Item
Item 13 Total
12

NA

NA

NA

NA

Yes

NA

Yes

Unclear

6

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

12

Yes

Yes

No

Yes

Unsure

Yes

Yes

Unsure

8

Yes

Yes

Yes

Yes

Yes

Yes

Yes

Yes

11

Yes

Yes

Yes

Yes

No

Yes

Yes

Unsure

11

Yes

Yes

Unsure

Yes

Unsure Unsure

Yes

Unsure

5

NA

NA

NA

NA

Unsure

Yes

Unsure

1

H.T. Hoang,
No
Yes∗
1 2019, Vietnam
Yes
Yes
Yes∗
[32]
S.M. Zick,
2
Yes
Yes
Yes
No
Yes
2016, USA [22]
Y.L. Zhao,
3 2015, China
Yes
Yes
No
No
Yes
[29]
W.R. Tan,
4 2014, Taiwan
Yes
No
Yes
No
Yes
[30]
S. Bokmand,
5 2013, Denmark Yes
Yes
Yes∗∗ Yes∗∗ Yes∗∗
[19]
Y. Feng, 2011,
Yes Unsure Unsure Unsure Unsure
6
China [21]
S. David, 2010,
Unsure Unsure
No
No
No
7
USA [31]

NA

Item 1. “Was the method of randomization adequate?” Item 2. “Was the treatment allocation concealed?” Item 3. “Was the patient blinded to the intervention?” Item 4. “Was the care provider blinded to the intervention?” Item 5. “Was the outcome assessor blinded to the intervention?” Item 6. “Was the
drop-out rate described and acceptable?” Item 7. “Were all randomized participants analyzed in the group to which they were allocated?” Item 8. “Are reports
of the study free of suggestion of selective outcome reporting?” Item 9. “Were the groups similar at baseline regarding the most important prognostic
indicators?” Item 10 “Were cointerventions avoided or similar?” Item 11 “Was the compliance acceptable in all groups?” Item 12 “Was the timing of the
outcome assessment similar in all groups?” Item 13. “Are other sources of potential bias unlikely?—Source: A. D. Furlan, A. Malmivaara, R. Chou, C. G.
Maher, R. A. Deyo, M. Schoene, . . . M. W. Van Tulder (2015). 2015 updated method guideline for systematic reviews in the Cochrane Back and Neck Group.
Spine, 40(21), 1660-1673. NA: not applicable due to the nature of registered ongoing/completed trials without publishing the ﬁnal results. ∗ The trial
investigator stated that a partial blinding design was utilized for participants in the true and sham acupressure groups. Partial blinding design was also used for
the true and sham intervention groups given the outcome assessors were the study participants themselves. ∗∗ The clinical study authors stated that
acupuncture group and sham acupuncture group were both patient- and investigator-blinded. Subjective symptoms were self-assessed and the outcome
assessors were therefore deemed as the participants themselves.

Two ongoing or completed registered trials evalauted
QoL, which was measured by the Functional Assessment of
Cancer Therapy-General scale [32] and the Functional
Assessment of Chronic Illness Therapy-Fatigue subscale
[31]. Results for these outcomes have not been reported yet
[31, 32].
3.5.6. Adverse Events. Adverse events or safety related to SAS
were mentioned in three trials [19, 22, 29]. One trial reported
that four women experienced mild and temporary adverse
events, and one woman experienced mild but long-lasting
adverse events in the acupuncture group [19]. Zick et al.
reported that six nonserious cases were related to acupressure
treatment, and all adverse events were mild bruising at
acupressure sites [22]. Another study reported that no adverse
events were found in the acupuncture and control groups, and
no participants dropped out of the study because of adverse
events [29]. Zick et al. reported that one participant dropped
out due to the adverse eﬀects of acupressure: bruising [22]. No
included trials performed causality analysis between the reported adverse events and the intervention.
3.5.7. Satisfaction with Treatment. No included trials reported participants’ satisfaction with treatment.

3.5.8. Cost-Eﬀectiveness. No included trials reported on
costs of SAS.

4. Discussion
This systematic review included ﬁve published studies and
two registered ongoing or completed clinical trials. Results
of the ﬁve published studies showed that SAS could potentially relieve cancer-related sleep disturbance and improve
QoL of patients with cancer. However, none of the included
RCTs can be used in the meta-analysis because they utilized
diﬀerent intervention protocols and measurement instruments (indicating substantial clinical heterogeneity) or because they did not include the data of their results.
Methodological quality of the included studies was identiﬁed
to be suboptimal. The duration of follow-up was short in most
of the included studies, and only one study reported a 6month follow-up after the completion of acupuncture [31].
Large-scale and well-designed clinical trials with long-term
follow-up are warranted to further explore the eﬀects of SAS
on cancer-related sleep disturbance
One relevant systematic review summarized RCTs on
acupuncture for cancer-related insomnia, and two of its
analyzed trials were included in our systematic review as well
[23]. We excluded electroacupuncture and auricular acupuncture studies that were originally included in the review
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by Choi et al. [23], and included acupressure, an important
type of SAS that is frequently used for cancer symptom
management, in this review to comprehensively explore the
current evidence on SAS for managing cancer-related sleep
disturbance. The prior published review concluded that, on
the basis of a low level of evidence, acupuncture might be
more eﬀective in reducing cancer-related insomnia than
sham acupuncture, conventional medications, or hormone
therapy [23]. Another relevant systematic review included 41
publications, three of which were related to acupuncture for
cancer-related sleep disturbance, exhibited a high risk of
bias, and reported positive outcomes [33]. The current review is consistent with previous reviews, indicating that SAS
may be a useful approach to relieving cancer-related sleep
disturbance. Nevertheless, recommending SAS for the
management of sleep disturbance in patients with cancer
may be premature due to the inconclusive evidence identifed
through current literature.
By reviewing the RCTs included in this systematic review,
we found that the SAS intervention protocols, including the
selected acupoints, number of treatment sessions, duration of
stimulation, and type of stimulation, varied signiﬁcantly
across studies. For instance, although some acupoints, such as
Sanyinjiao (SP6), Yintang (EX-HN3), and Baihui (DU/
GV20), were frequently used in several included studies, none
of the included trials employed a standardized acupoint
formula that higlights the main acupoints for managing
cancer-related sleep disturbance. Manual acupuncture was
typically 15–30 min in duration and was conducted once a
day or once a week for a period of 1–5 weeks, whereas selfadministered acupressure was typically conducted for
1–3 min per point once a day for a period of 1-5 months.
However, none of the included studies investigated the
“dosage eﬀects” of the SAS intervention protocols, such as the
eﬀects of variations in the acupoint formula, intervention
duration and frequency, on sleep quality in cancer patients.
Four trials compared true SAS interventions with sham
(placebo) interventions [19, 30–32]. Two studies described
the design of sham acupuncture or sham acupressure, and a
similar approach was used for sham SAS which selected
several nonacupoints in the same region as the true acupoints used in the intervention group [19, 30, 32]. Only one
study highlighted that the selected sham acupoints were
located away from meridians [19]. The sleep quality of
participants in the true SAS intervention group signiﬁcantly
improved compared with that in the sham SAS group
[19, 30] which supports the speciﬁc treatment eﬀects of SAS.
A further comparison between the sham SAS and no intervention was performed in only one study [19] which
concluded no between-group diﬀerence. It was diﬃcult to
identify the size of the SAS placebo eﬀects from the included
studies given that only one small scale study reported statistical comparisons between the sham SAS and no treatment [19].
No serious adverse events were found in the included
trials. SAS-related adverse events were mentioned in three
trials, and all adverse eﬀects were deemed to be mild
[19, 22, 29]. Based on the limited information regarding the
safety of SAS in the included studies, SAS could be used as a
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safe intervention for cancer symptom management with
only mild adverse events occasionally reported. Some of the
adverse events, such as mild bruising, can be eﬀectively
managed and prevented once proper SAS training and
precautions are provided. SAS should be performed or
taught only by a well-trained and qualiﬁed therapist, acupuncturist, or TCM practitioner. It should be noted that
none of the included trials assessed the causality between the
reported adverse events and the SAS, and some potential
adverse events might be underreported given that most of
the included studies recruited only a small number of
participants.

5. Quality of the Evidence
Limited information can be used to assess the methodological quality of ongoing or completed registered trials
[31, 32]. A successful design and implementation of blinding
in SAS trials has been signiﬁcantly challenging given that the
treatment and control procedures are conspicuously different in nature. Considering that some outcomes, such as
sleep parameters in a sleep diary and patient-reported
questionnaires, were completed by the participants themselves, reporting bias is possible in the included studies. The
long-term eﬀects of SAS on cancer-related sleep disturbance
have not been investigated. In addition, the sample sizes of
the included trials are small and the eﬀects of SAS may thus
have been underestimated.

6. Implications for Further Research
and Practice
The beneﬁcial role of SAS in managing cancer-related sleep
disturbance is promising; however, the evidence remains
inconclusive given the limited quantity and quality of the
included trials as well as the small sample size identifed in
some of the trials. Two included studies primarily focused on
the eﬀects of SAS on cancer-related fatigue while sleep
disturbance was only included as a secondary outcome
[22, 30]. Clinical trials with large sample sizes and robust
methodology are warranted in future research to further
explore the eﬀects of SAS on cancer-related sleep disturbance. Identifying the types of SAS and acupoint formula
that work best for cancer-related sleep disturbance and the
optimal SAS intervention frequency and duration are the key
to develop an evidence-based SAS intervention protocol for
managing cancer-related sleep disturbance.
Only four of the included studies used sham SAS as a
comparative treatment, wherein some nonacupoints in the
same region as the true acupoints used in the study intervention were selected [19, 30–32]. However, some of the
nonacupoints might be located near the meridians, which
might further generate some unwanted speciﬁc treatment
eﬀects on sleep problems and further undermine the causality assessment between the ture SAS and patient sleep
outcomes. Appropriate sham SAS design is recommended in
future research to distinguish the speciﬁc therapeutic eﬀects
of SAS from its non-speciﬁc placebo eﬀects [34]. Locations
of the selected nonacupoints in the sham SAS group should
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be away from meridians to avoid triggering speciﬁc treatment eﬀects of acupoint stimulation. Future studies should
also include a long-term follow-up to evaluate the long-term
eﬀects and safety of using SAS for cancer-related sleep
disturbance management. Causality analysis should be
performed between the reported adverse events and the
intervention. SAS should be performed and taught only by
well-trained practitioners to minimize potential adverse
eﬀects and unsafe practice.
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7. Conclusion
This systematic review showed that SAS is a useful approach
to relieving cancer-related sleep disturbance. However, research evidence on SAS for managing cancer-related sleep
disturbance has not been fully conclusive due to the limited
number of existing clinical studies with relatively small
sample size and suboptimal methodological quality. Clinical
trials with large sample size and robust methodology are
warranted in future research.
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